Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

The FDA has rejected Sanofi's application seeking approval of tolebrutinib to treat certain forms of MS in its present form.

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

Exposure to common environmental chemicals, especially in combination, is linked to an increased risk of multiple sclerosis.

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

New Swedish research finds that people with highest microplastics and PFAS levels face double the risk of multiple sclerosis ...

Proving her illness created an illusion of wellness for columnist Ahna Crum, but a relapse after nine years showed her she ...

High levels of the periodontal bacterium Fusobacterium nucleatum may be associated with more severe disability in people with multiple sclerosis.

During an episode of her MeSsy podcast with co-host Christina Applegate, the actress, 44, opened up about her decision not to ...